After its recent funding round, HiFiBiO pens Takeda R&D collaborationAllbiopro2018-07-31T09:50:24+09:007월 31st, 2018|
Amarin’s Vascepa goes on TV to lay groundwork for impending CV outcomes dataAllbiopro2018-07-31T09:49:31+09:007월 31st, 2018|
RedHill’s RHB-104 hits primary endpoint in Crohn’s phase 3Allbiopro2018-07-31T09:46:45+09:007월 31st, 2018|
Lonza: CAR-T Manufacturing Glitch an Industry Problem, not Just Novartis’sAllbiopro2018-07-31T09:45:48+09:007월 31st, 2018|
Bioproduction: A ‘Tale of Two Facilities,’ Says JacobsAllbiopro2018-07-31T09:44:50+09:007월 31st, 2018|
Diatom ooze sediments are a large marine mercury sinkAllbiopro2018-07-31T09:41:15+09:007월 31st, 2018|
Novartis Partners with MorphoSys, Galapagos in $1.1-Billion mAb DealAllbiopro2018-07-31T09:40:33+09:007월 31st, 2018|
Eye on Pharma: Positive Phase 1 Data for Glenmark’s Omalizumab BiosimilarAllbiopro2018-07-27T00:31:40+09:007월 27th, 2018|
On the Heels of Latest Biosimilar Approval, Pfizer Calls for a Change in the MarketAllbiopro2018-07-27T00:31:13+09:007월 27th, 2018|
Roche Quarterly Financials: “Firing on All Cylinders”Allbiopro2018-07-27T00:29:55+09:007월 27th, 2018|
AstraZeneca’s Cancer Drugs Mostly Soar With One Bomb Amidst Quarterly ReportAllbiopro2018-07-27T00:29:29+09:007월 27th, 2018|
